Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series.
Dietz-Fricke C, Degasperi E, Jachs M, Maasoumy B, Reiter FP, Geier A, Grottenthaler JM, Berg CP, Sprinzl K, Zeuzem S, Gödiker J, Schlevogt B, Herta T, Wiegand J, Soffredini R, Wedemeyer H, Deterding K, Reiberger T, Lampertico P.
Dietz-Fricke C, et al. Among authors: degasperi e.
Hepatology. 2024 Mar 13. doi: 10.1097/HEP.0000000000000847. Online ahead of print.
Hepatology. 2024.
PMID: 38478755